TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of mortalities among STEMI patients
Endpoint domain: Mortality/survival
Primary endpoint: Number of mortalities among NSTEMI patients
Endpoint domain: Mortality/survival
Primary endpoint: Craving for alcohol during the cue reactivity task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resting state functional connectivity during tDCS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Brain activation to alcohol cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Intervention-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Leak Point Pressure (LPP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cell death index measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pressure ulcer risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nursing knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: General self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diabetes Foot Knowledge Level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Foot Care Behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot Care Self-Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Satisfaction With Ocrelizumab SC
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical patient reported outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Back Belief Questionnaire (BBQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence Rate of Lower Limb Amputation
Endpoint domain: Mortality/survival
Primary endpoint: Joint Contact Stress Exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete clinical response (cCR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TB disease-free survival at 48-weeks
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of participants with grade 3 or higher adverse events over 28 weeks
Endpoint domain: Adverse events/effects
Primary endpoint: change in neck pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change of FACIT-F score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Reduction in signs and symptoms of contact/irritant dermatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in functional connectivity of the M1 with brain areas involved in pain processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in brain metabolism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in brain plasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: stringent Complete Response (sCR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritable Bowel Syndrome-Symptom Severity Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of Time Spent in HCL After CGM Sensor Meets Initial Validation Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of Time Sensor Glucose is Within Target Glucose Range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Event-free survival at 1 year post transplantation
Endpoint domain: Mortality/survival
Primary endpoint: Structured Clinical Interview for DSM-5 Sleep Disorders- Revised (SCISD-R)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nightmare Disorders Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Patient functional independence assessed with Barthel Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient functional independence assessed with Stroke Impact Scale-16
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Patient disability assessed with Modified Rankin Scale (mRs)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Defocus curve comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Craving Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dot Matrix Working Memory Task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Concordance between eBAM-Cov test and RT-PCR test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in VAS score for reflux and heartburn symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in VAS score for abdominal pain and diarrhea symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Disease progression identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic yield of 3D-MPUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of walking sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Body Mass Index (BMI) %95 in children with obesity (treatment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Body Mass Index (BMI) %95 in healthy and overweight children (prevention)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Adherence to Liraglutide
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Accelerated weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum blood concentration of Huperzine A (Cmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Area under the Huperzine A blood concentration-time curve from 0min to the time of last concentration (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Area under the Huperzine A blood concentration-time curve from 0min to the infinity time (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Production of target sentences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehension of target sentences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real-time comprehension of target sentences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparedness for survivorship
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: specific cellular response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Acceptance and tolerance of high calorie formula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Numeric Pain Rating Scale (NPRS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Oswestry disability index questionnaire (ODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Subjective Pain Scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcutaneous carbon dioxide levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper limbs muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Generalization performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of rotigotine
Endpoint domain: Adverse events/effects
Primary endpoint: Tibial Motor Nerve Conduction Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fibular Motor Nerve Conduction Velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement rate at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative subjective emotional experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sensitivity and specificity of 18F-PFPN PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of parents engaging with and finishing the program
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Compliance and satisfaction throughout the study
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parents' acceptability and satisfaction with the program
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Objective Response Rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Knee Extension Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac health assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 3 year Overall Survival (OS) rate
Endpoint domain: Mortality/survival
Primary endpoint: Perianal pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perianal irritation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC (area under the curve) 0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: K el
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secondary attack rate (SAR) of Mpox virus
Endpoint domain: Mortality/survival
Primary endpoint: Maximal decrease in glottic anterior angle (degrees) during challenge testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal increase in glottic anterior angle (degrees) after challenge testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal laryngeal relaxation time (seconds)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of axitinib + pembrolizumab versus axitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Interval Cancer Rate
Endpoint domain: Mortality/survival
Primary endpoint: Emotionally unstable personality disorder syndrome severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tumor cells proliferation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cell cycle arrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Apoptosis marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Health state utilities based on Rickets Severity Score (RSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health state utilities based on EQ-5D-Y
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Health state utilities based on Child Health Utility 9 Dimensions [CHU-9D]
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Lung Volume Initiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Lung Volume Termination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Lung Volume Excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Cepstral Peak Prominence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Cepstral/Spectral Index of Dysphonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic accuracy of cesarean scar defect assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Assessment of pain using Visual analog scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total amount of analgesic
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Size of edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Metabolic Equivalents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in knowledge questionnaire score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Allergic reaction to food challenge
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of time in saturation target
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Success rate of ultrasound guided subclavian vein cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients with limiting-toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Minimal residual disease (MRD) negative Complete remission (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: B cell aplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Subcutaneous collection with vacuum drain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Subcutaneous collection with passive drain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Acceptability at inclusion
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognition - Computerized Cognitive Tasks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Self-Efficacy - Cognitive Failures Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Behavioral Sleep - Electronic Daily Sleep Diaries
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Behavioral Sleep - Insomnia Severity Index
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Sleep - Watchpat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy after the second dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCt of CKD-501, D759, H053
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of CKD-501, D759, H053
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic intracranial hemorrhage (sICH) at 24 hours post-procedure
Endpoint domain: Adverse events/effects
Primary endpoint: Change in clinical fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Total number of days absent from work due to COVID-19
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Hospital Readmission Reduction
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Pulmonary Rehabilitation Uptake
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pulmonary Rehabilitation Delivery and Completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Nordic Musculoskeletal Questionnaire (NQS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Internet Addiction Test (IAT)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Keloid regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Accuracy of the Serum Raman Spectroscopy Intelligent System
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression and regression of neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety of TMB-365 and TMB-380
Endpoint domain: Adverse events/effects
Primary endpoint: Pharmacokinetics of TMB-365 and TMB-380
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antiviral activity of TMB-365 and TMB-380
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: fMRI Intrinsic Connectivity: Default Mode Network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: fMRI Intrinsic Connectivity: Frontoparietal Control Network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: fMRI Intrinsic Connectivity: Limbic Network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: fMRI Intrinsic Connectivity: Salience Network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transcutaneous partial pressure of CO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in respiratory functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change in bronchospasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: change in amount of ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Risk marker profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Parental anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: C. acnes relative abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Microbiome outcomes
Primary endpoint: Evaluation of Fine Motor Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attention and Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of treatment for iron deficiency anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Face Looking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body Looking, Toy and Environment Looking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Fixations during Obstacle Encounter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Fixations during Manual Encounter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Encounter
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Fixations to Destinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in total puff volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of fatalities associated with prescription opioids
Endpoint domain: Mortality/survival
Primary endpoint: Bipedal height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thirty-Second Chair Stand (30-s chair stand)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Timed Up-and-Go (TUG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sit-and-Reach Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-min Step Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in aerobic exercise behaviour (objective measure)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in aerobic exercise behaviour (subjective measure)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy and reliability of blood glucose measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of Nystagmus detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Distribution of clinical conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-reported alcohol use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Local-regional Recurrence Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Cognitive Complaints in Bipolar Disorder Rating Assessment (COBRA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Fatigue index (FI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Fatigue
Primary endpoint: Countermovement vertical jump (CMJ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predictor for spermatogenesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change in Burnout Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Relative expression of Trem2 and insulin-like 3 protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Return of skin integrity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Computed Tomography (CBCTs) received
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fugl-Meyer Assessment Upper Extremity (FMA-EU) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nine Hole Peg Test Value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes